Priority should be given to studies that simultaneously examine multiple hormone receptors (ER, PR, AR, GnRH-R, GPER) across different menstrual cycle phases and compare the adenomyosis lesions to specific endometrial subregions. This evidence concerns the gene NR4A1 and adenomyosis.